| 2026-05-06 | 10-Q | 10.1 | Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated February 18, 2026. |
|---|
| 2026-02-24 | 10-K | 10.11 | Offer Letter entered into by and between Registrant and Harp Dhaliwal, dated September 29, 2021. |
|---|
| 2025-12-19 | 8-K | 10.1 | Form of Amendment to Executive Change in Control and Severance Agreements. |
|---|
| 2025-11-04 | 10-Q | 10.1 | Commercial Manufacturing and Supply Agreement by and between the Registrant and Patheon Manufacturing Services LLC (part of Thermo Fisher Scientific), dated September 24, 2025. |
|---|
| 2025-05-07 | 10-Q | 10.2 | Form of Performance Contingent Stock Option Grant Notice and Agreement. |
|---|
| 2025-05-07 | 10-Q | 10.1 | Form of Performance Restricted Stock Unit Award Grant Notice and Agreement. |
|---|
| 2025-02-25 | 10-K | 10.22 | Amended and Restated Lease Agreement by and between the Registrant and ARE-San Francisco No. 63, LLC, dated as of November 15, 2024 |
|---|
| 2024-02-27 | 10-K | 10.27 | Form of Non. U.S. Restricted Stock Unit Grant Notice (2020 Equity Incentive Plan). |
|---|
| 2024-02-27 | 10-K | 10.26 | Form of Non-U.S. Stock Option Grant Notice and Stock Option Agreement (2020 Equity Incentive Plan). |
|---|
| 2024-02-27 | 10-K | 10.23 | First Amendment to Lease Agreement by and between the Registrant and ARE-San Francisco No. 63, LLC, dated October 17, 2023. |
|---|
| 2024-02-27 | 10-K | 10.21 | First Amendment to License Agreement by and between the Registrant and The Regents of the University of California, represented by its San Diego campus, dated August 16, 2019. |
|---|
| 2024-02-27 | 10-K | 10.19 | Supply Agreement by and between the Registrant and Sutro Biopharma, Inc., dated May 29, 2018, as amended. |
|---|
| 2024-02-27 | 10-K | 10.14 | Commercial Manufacturing and Supply Agreement by and between the Registrant and Lonza Ltd., dated October 13, 2023. |
|---|
| 2024-02-27 | 10-K | 10.12 | Master Services Agreement for Drug Product Development and Manufacturing between Registrant and Lonza Ltd., dated March 22, 2022, as amended. |
|---|
| 2023-11-06 | 10-Q | 10.3 | Third Amendment to Amended and Restated SutroVax Agreement by and between Sutro Biopharma, Inc. and the Registrant, dated September 28, 2023. |
|---|
| 2023-11-06 | 10-Q | 10.2 | Consent to Assignment and First Amendment by and among ARE-San Francisco No. 63, LLC, Codexis, Inc. and the Registrant, dated September 6, 2023. |
|---|
| 2023-11-06 | 10-Q | 10.1 | Assignment and Assumption of Lease Agreement by and between the Registrant and Codexis, Inc., dated September 1, 2023. |
|---|
| 2023-08-08 | 10-Q | 10.2 | Form of Stock Option Grant Notice and Stock Option Agreement. |
|---|
| 2023-08-08 | 10-Q | 10.1 | Vaxcyte, Inc. 2020 Equity Incentive Plan. |
|---|
| 2023-05-08 | 10-Q | 10.1 | Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated March 1, 2023. |
|---|
| 2023-02-27 | 10-K | 10.20 | Option Grant Agreement by and between Registrant and Sutro Biopharma, Inc., dated December 19, 2022. |
|---|
| 2023-02-27 | 10-K | 10.19 | Supply Agreement by and between the Registrant and Sutro Biopharma, Inc., dated May 29, 2018, as amended. |
|---|
| 2023-02-27 | 10-K | 10.17 | Master Services Agreement for Drug Product Development and Manufacturing between Registrant and Lonza Ltd., dated March 22, 2022, as amended. |
|---|
| 2023-02-27 | 10-K | 10.15 | Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd, dated October 21, 2016, as amended. |
|---|
| 2023-02-27 | 10-K | 10.11 | Offer Letter entered into by and between the Registrant and Harpreet Dhaliwal, dated September 29, 2021. |
|---|
| 2022-11-07 | 10-Q | 10.1 | Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended |
|---|
| 2022-08-08 | 10-Q | 10.2 | Master Services Agreement for Drug Product Development and Manufacturing between the Registrant and Lonza Ltd., dated March 22, 2022, as amended |
|---|
| 2022-08-08 | 10-Q | 10.1 | Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended |
|---|
| 2022-05-09 | 10-Q | 10.2 | Form of Restricted Stock Unit Grant Notice |
|---|
| 2022-05-09 | 10-Q | 10.1 | Offer Letter entered into by and between the Registrant and Mikhail Eydelman, dated March 4, 2022. |
|---|
| 2021-11-10 | 10-Q | 10.1 | Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended. |
|---|
| 2021-05-11 | 10-Q | 10.1 | Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd, dated October 21, 2016, as amended. |
|---|
| 2021-01-25 | 8-K | 10.1 | Lease Agreement by and between the Company and ARE-San Francisco No. 63, LLC, dated as of January 21, 2021 |
|---|